[Mizoribine].
Kondo
Hirobumi
H
Department of Internal Medicine, Kitasato University School of Medicine.
Iizuka
Nobuko
N
D000818:Animals; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D003864:Depression, Chemical; D006157:Guanosine Monophosphate / Q000378:metabolism; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D008181:Lupus Nephritis / Q000188:drug therapy; D008213:Lymphocyte Activation / Q000187:drug effects; D051379:Mice; D011687:Purines / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D012263:Ribonucleosides / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology; D012859:Sjogren's Syndrome / Q000188:drug therapy; D013601:T-Lymphocytes / Q000276:immunology
D007166:Immunosuppressive Agents; D011687:Purines; D012263:Ribonucleosides; C010052:mizoribine; D006157:Guanosine Monophosphate; C030985:purine